AGNPF logo

AGNPF Grey Matters Health Inc.

Other OTC · Biotechnology · Healthcare

$0.25
-0.03 (-9.39%)

Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off l…

Market Cap: $1.35Mwww.greymatters-health.com

Price

No data yet.

Social Signal Score

37
5d
—
30d
30
1 mentions
—
60d
40
4 mentions
—
90d
40
4 mentions
—
news: 4

Revenue

$0.00
$0.00
Aug 2016May 2026

Analyst Estimates

FY2025
$-2.40
$-2.40–$-2.40
1 analysts
FY2026
$-2.56
$-2.56–$-2.56
1 analysts
FY2027
$6.98
$6.98–$6.98
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Christopher J. Moreau
Sector
Healthcare
Industry
Biotechnology
Employees
5
Beta
0.29
Country
CA
Piotroski score
2 / 9 (Weak)
Altman Z-score
-9.67
www.greymatters-health.com